Erik Hakansson
Overview
Explore the profile of Erik Hakansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norberg H, Andersson T, Hakansson E, Angerud K, Lindmark K
Eur J Clin Pharmacol
. 2024 Jun;
80(9):1363-1371.
PMID: 38856725
Objective: To assess a systematic implementation approach for introducing dapagliflozin to individuals with heart failure and reduced ejection fraction in an outpatient clinical setting. Methods: Retrospective medical record data were...
2.
Hakansson E, Brunstrom M, Norberg H, Sjalander S, Lindmark K
Open Heart
. 2023 Jan;
9(2).
PMID: 36600650
Aims: The aim of this study was to investigate a real-world heart failure (HF) cohort regarding (1) prevalence of known diabetes mellitus (DM), undiagnosed DM and pre-diabetes, (2) if hf...
3.
Hakansson E, Norberg H, Sjalander S, Lindmark K
Cardiovasc Ther
. 2022 Jan;
2021:1894155.
PMID: 35024052
Aims: This study is aimed at investigating the eligibility in a real-world heart failure population for the DAPA-HF (testing dapagliflozin) and EMPEROR-reduced (testing empagliflozin) trials, comparing the eligible real-world patients...
4.
Ullmark T, Montano G, Jarvstrat L, Nilsson H, Hakansson E, Drott K, et al.
Biochem Biophys Res Commun
. 2016 Nov;
482(4):802-807.
PMID: 27889611
Wilms' tumor gene 1 (WT1) is a zinc finger transcription factor that has been implicated as an oncogene in leukemia and several other malignancies. When investigating possible gene expression network...
5.
Olsson A, Alfredsson J, Hakansson E, Svedjeholm R, Berglund J, Berg S
Scand Cardiovasc J
. 2015 Sep;
50(1):58-63.
PMID: 26402229
Objectives: Platelet dysfunction is an important cause of postoperative bleeding after cardiac surgery. Protamine is routinely used for reversal of heparin after cardiopulmonary bypass (CBP), but may affect platelet aggregation....